hemostasis after femoral artery access cardiovascular interventions in everyday practice.
To assess the safety and efficacy of carbon dioxide (CO2) angiography-guided endovascular therapy (EVT) for renal, iliofemoral artery disease.
METHOD A prospective multi center registry was developed and six clinical centers participated in the study. Patients with an estimated glomerular filtration rate (eGFR) of <60 ml/min/1.73 m2 andstage-3 CKD were recruited between February 2012 and March 2013. CO2 angiography-guided EVT was performed; incomplete CO2 angiograms were supplemented by intravascular ultrasound, pressure wire, and/or minimal iodinated contrast media. The primary endpoint was a composite of freedom from renal events and freedom from major CO2 angiography related complications.
RESULTS
This study included 98 patients with 109 lesions. The mean eGFR baseline was 35.2 AE 12.7 ml/min. CO2 angiographyguided angioplasty were performed in 16 renal arteries, 31 aortoiliac arteries, and 62 superficial femoral arteries. The technical success rate was 97.9%. Average CO2 consumption was 281.4 AE 155.8 ml, average dose of iodinated contrast media was 15.0 AE 18.1 ml. Primary endpoint was 92.8% (91/98). Incidence of CIN was 5.1 %( 5/98) and CO2 angiography-related complications occurred in 17.3% (17/ 98). Two cases (2%) developed severe, fatal, nonocclusive mesenteric ischemia (NOMI).Further analysis, CIN occurred the patients those SFA lesions, chronic total occlusion and high volume CO2 injection.
CONCLUSION This trial showed that CO2 angiography-guided angioplasty was effective for preventing CIN, however, CO2 angiography related complication was somewhat high. And large amount of CO2 can cause CIN. METHODS This was a retrospective case series study conducted in cardiac intervention center of Princess Margaret Hospital on patients who had FFR measured during PCI. Either adenosine or adenosine triphosphate were given by intravenous infusion or intracoronary bolus injection. The aim was to examine the medium term safety of deferring PCI.
PHYSIOLOGIC LESION ASSESSMENT (TCTAP
RESULTS Three hundred and six consecutive patients (53 female, 253 male) of age 63þ/-11 were recruited. Measuring FFR was unequivocal and successful in 384 lesions. There was no procedure related complication. FFR was measured in 203 lesions in left anterior descending artery (LAD), 91 lesions in left circumflex artery (LCX) and 90 lesions in right coronary artery (RCA). PCI was avoided in 109 (54%) lesions in LAD, 73 (80%) lesions in LCX and 66 (67%) lesions in RCA. After follow-up of 1125þ/-459 days, ten (3.3%) patients subsequently received PCI in the vessel with FFR deferred lesion. There was no death related to FFR deferred lesion. BACKGROUND We sought to use combined intracoronary pressure and flow velocity measurements to elucidate of the behavior of the human coronary circulation in response to a stenosis.
CONCLUSION
METHODS 567 simultaneous intracoronary pressure and flow velocity assessments were analyzed for coronary flow velocity, transtenotic gradient (TG) and microvascular resistance (MVR). Measurements were made during rest, over the whole cardiac cycle resting and the diastolic wave-free period, and during adenosine-mediated hyperemia. Linear regression analysis estimated trends and P-values, according to stenosis severity as determined objectively by fractional flow reserve (FFR).
RESULTS As stenosis severity increases, from unobstructed angiographically normal vessels to those with FFR 0.50, resting flow velocity was (18AE8.2 cm/s; P¼0.40); hyperemic flow falls from 45 to 19 cm/s at hyperemia (P<0.01). TG increases from 1.5 to 46 mmHg at rest, and from 3.5 to 55 mmHg at hyperemia (P<0.01 for both). MVR declines from 6.2 to 4.2 atrest (P<0.01), but remained unchanged at hyperemia (2.3AE1.1; P¼0.19). Phasic analysis during the wave-free period, yielded similar trends as whole cycle analysis. 
